Navigation Links
Lotus Pharmaceuticals, Inc. to Exhibit at the 2009 International Conference for Bioeconomy
Date:6/17/2009

BEIJING, June 17 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer and producer of prescriptions drugs and licensed national seller of pharmaceutical products in the People's Republic China, today reported it will exhibit at the main Medicine Hall at the 2009 International Conference for Bioeconomy to be held from June 26 to June 28 in Tianjin, China.

About the 2009 International Conference for Bioeconomy-the 44th New Drugs Expo

The 2009 International Conference for Bioeconomy, sponsored by Ministry of Science and Technology, State Food and Drug Administration, and the Tianjin Municipal Government, is aimed to tackle financial crisis with the development of bio-economy. It provides a platform for marketing, networking, strategic partnership and information exchange. It is one of the largest and most reputable biotech and new drugs conferences in China. About 3,000 domestic and foreign companies are expected to be present at the exhibition. Eleven breakout sessions will be held to discuss frontier bio-technologies applied in life sciences, medicine, agriculture, energy, resources, environment and etc. For more information, please visit http://www.bioeco.net.cn .

About Lotus Pharmaceuticals, Inc. ( http://www.lotuspharma.com )

Lotus Pharmaceuticals, Inc. is a growing developer and producer of prescription drugs and a licensed national seller of pharmaceutical items in the People's Republic of China. Lotus operates Liang Fang Pharmaceutical, Ltd. and En Ze Jia Shi Pharmaceutical, Ltd. Lotus's current drug development pipeline is focused on the treatment of cerebro-cardiovascular disease, asthma, and diabetes. More than 8,000 products are sold by Liang Fang directly and indirectly through its national sales channels to hospitals, clinics and drugs stores in 30 provinces.

    For more information, please contact:

    Lotus Pharmaceuticals, Inc.
     Yan Zeng, CFO
     Phone:  +8610-6389-9868
     Email: zy@lotuspharma.com
     Web:  http://www.lotuspharma.com

'/>"/>
SOURCE Lotus Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Lotus Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results
2. Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results
3. iEnterprises Launches iComply, Lotus Notes Email Archiving and Compliance Software
4. Lotus Pharmaceuticals, Inc. Purchases Intellectual Property Rights to an Established Prescription Drug
5. Lotus Pharmaceuticals, Inc. Purchases Land Use Rights to Grow its Business and Reduce Costs
6. Lotus Pharmaceuticals to Present at Rodman & Renshaw Conference
7. Lotus Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2008 Results
8. Lotus Pharmaceuticals, Inc. Reaffirms its Confidence in Meeting its Make Good Target for Fiscal Year 2008
9. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss First Quarter 2008 Results
10. Lotus Pharmaceuticals, Inc. Announces Resignation of Director Mel Rothberg
11. Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... Are you ... tragic spike in water-related accidents and drownings during the summer. While most of us ... that these situations occur every day. Very few people are taking the time to ...
(Date:4/26/2017)... ... 26, 2017 , ... Intalere, the healthcare industry leader in ... Plans for MACRA,” highlighting the impact of the Medicare Access and CHIP ... and other clinicians are reimbursed for the care they deliver in Medicare. , ...
(Date:4/26/2017)... ... April 26, 2017 , ... CareSet Labs today is ... as measured in Part D Medicare data. The dataset, called PaPR (Providers and ... e-prescribing, faxes or paper. The PaPR (pronounced "paper") data set aggregates this ...
(Date:4/26/2017)... ... 2017 , ... The National Business Research Institute (NBRI) is ... Emergency Medical Technicians and welcomes this organization to the NBRI Circle of ... Ph.D. , CEO & Organizational Psychologist at NBRI. “This award is a result ...
(Date:4/26/2017)... ... April 26, 2017 , ... RawTrition now brings you BioEnergy which is a ... SUPERFOODS! , RawTrition is taking nutrients to the next level! The ... recognizes its raw form (unlike the synthetically made options that are on the market). ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 Global ... This report on the prostate cancer therapeutics market ... global market. Increasing prevalence of prostate cancer, launch ... in the development of new drugs & therapeutic ... cancer drug due to lesser side effects are ...
(Date:4/19/2017)... , April 19, 2017  New research provides evidence that ... Parkinson,s, according to a study released today that will be ... Meeting in Boston , April 22 ... the treatment of Parkinson,s disease, the oral drug levodopa has ... and longevity. But as the disease progresses, the effects of ...
(Date:4/18/2017)... April 18, 2017 Viverae ® , a ... the integration of IBM ® Watson Campaign Automation, ... targeted communications for a personalized experience. Through digital engagement, ... their health in real time. The enhanced experience drives ... to members, wherever they are in their journey to ...
Breaking Medicine Technology: